Skip to Content


In the US, Vigabatrin (vigabatrin systemic) is a member of the drug class gamma-aminobutyric acid analogs and is used to treat Epilepsy, Seizure Prevention and Seizures.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent

Chemical Name

5-Hexenoic acid, 4-amino-

Foreign Names

  • Vigabatrinum (Latin)
  • Vigabatrin (German)
  • Vigabatrine (French)
  • Vigabatrina (Spanish)

Generic Names

  • Vigabatrin (OS: BAN, USAN, JAN)
  • Vigabatrine (OS: DCF)
  • MDL 71754 (IS: MerrellDow)
  • RMI 71754 (IS: Merrell)
  • þ-Vinyl-GABA (IS)
  • Vigabatrin (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Vigabatrine (PH: Ph. Eur. 8)
  • Vigabatrinum (PH: Ph. Eur. 8)

Brand Names

  • Sabril
    Aventis, Poland; Benta, Lebanon; Euro Registratie, Netherlands; Lundbeck, Canada; Lundbeck, United States; Marion Merell, Oman; Marion Merrell, Tunisia; Sanofi, United Kingdom; Sanofi, Ireland; Sanofi Aventis, Brazil; Sanofi Aventis, Chile; Sanofi Belgium, Belgium; Sanofi Malta, Malta; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Colombia; Sanofi-Aventis, Germany; Sanofi-Aventis, Egypt; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Hungary; Sanofi-Aventis, Italy; Sanofi-Aventis, Latvia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Portugal; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, South Africa
  • Sabrilan
    Perrigo, Israel
  • Sabrilex
    Sanofi, Sweden; Sanofi Aventis, Spain; Sanofi Oy, Finland; Sanofi-Aventis, Denmark; Sanofi-Aventis, Iceland; Sanofi-Aventis, Norway; Hoechst-Biotika, Lithuania


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.